VelaVigo

Private

ShanghaiHealthcare & Life Scienceshttps://www.velavigo.com/

Last Round

VC Round

Jul 28, 2025

Total Funding Raised

$100M

Company Overview

VelaVigo is a biopharmaceutical company that specializes in the discovery and development of multispecific antibodies and antibody-drug conjugates for oncology and autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

biologic drug discovery and developmentmulti-specific antibody discovery platformantibody-drug conjugate (ADC) development platformpreclinical drug candidate out-licensingfirst-in-class (FIC) biologic drug candidatesoncology and autoimmune disease therapeuticsbispecific antibody developmentbiopharmaceutical asset licensingbest-in-class (BIC) drug candidatesNectin4/TROP2 bispecific ADC

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VelaVigo Comps

Public and private peers based on sector, stage, and business model.

VelaVigo comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

VelaVigo Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Jul 28, 2025
Pre Seed	Dec 31, 2024
Angel	Nov 15, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Tong Zhang

Co-founder, CBO CFO

Founding Team

Jing Li

Founder and CEO

Founding Team

Vilar Ye

Sr. Manager, CEO Office

Executive Team

VelaVigo Investors

Notable investors and investment history

VelaVigo investors
Investor	Rounds
HighLight Capital	VC Round, Pre Seed, Angel
Legend Star	VC Round, Pre Seed
Shanghai Healthcare Capital	VC Round, Pre Seed
Zoo Capital	VC Round, Pre Seed
Highlight Capital	VC Round, Pre Seed
Northern Light Venture Capital	VC Round
Delian Capital	VC Round, Pre Seed

View all Investors

VelaVigo Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

VelaVigo Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VelaVigo's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai

Employee Range19

Year Founded2021

Last FundingJul 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.